Ocado is the first supermarket to sell cannabis-infused water

The online supermarket Ocado is the first in the UK to sell water infused with cannabis oil.

From today, the site will sell Love Hemp Water, which is available from £1.29 and contains the cannabis-derived nutritional supplement cannabidiol (CBD).

Cofounder of the brand Tony Calamita said: ‘There’s a growing understanding of the wide ranging benefits of cannabis oil to health and wellbeing which is why we have launched the first every day hemp water product.

‘Each 500ml bottle of Love Hemp is sugar free and contains 2mg of natural hemp extract. It tastes great and is naturally hydrating.

‘We’re proud to be starting a hemp water revolution.’

A recent World Health Organization report suggests that CBD oil has benefits for Alzheimer’s, Parkinson’s, multiple sclerosis, pain, anxiety, depression, cancer and diabetic complications.

CBD does not contain any THC, which is the psychoactive component of cannabis that makes users ‘high’.

Love Hemp Water, which is available from £1.29 and contains the cannabis-derived nutritional supplement cannabidiol, will be sold at the online supermarket Ocado from today

WHICH COUNTRY IS THE BIGGEST CANNABIS PRODUCER?

The UK is the world’s biggest producer of medical cannabis.

Britain produced 95 tonnes of legal marijuana in 2016, making up 44.9 per cent of the world’s total, according to figures from the UN’s International Narcotics Control Board.

This is more than double the UK’s 42-tonne cannabis production in 2015, the data adds.

Of the marijuana produced, 2.1 tonnes were exported from the UK in 2016, making up 67.7 per cent of the global total, the figures show.

Despite this, medical cannabis licensed in other countries remains illegal in the UK even if deemed appropriate by a doctor.

Pro-legislation campaigners have described patients’ denied access to medical marijuana as ‘unethical’ and ‘a violation of the fundamental right to health’.

Steve Rolles, a senior policy analyst at drug-relation think tank Transform, said: ‘It is scandalous and untenable for the UK government to maintain that cannabis has no medical uses, at the same time as licensing the world’s biggest government-approved medical-cannabis production and export market.’

Holland and Barrett sales soared after introducing a cannabis-derived oil

Speaking of Ocado’s introduction of Love Hemp Water, which recently featured on ITV’s Gone To Pot: American Road Trip, a spokesperson said: ‘This is one of the most interesting new products we have seen.’

This comes after the high-street health-chain Holland and Barrett announced just last month it has seen a surge in sales since it began selling CBD oil in January.

The retailer, whose sales have soared by 37 per cent, is selling the oil for £19.99.

Holland & Barrett’s product has been launched as a food supplement, meaning the firm cannot claim any of the oil’s supposed health benefits.

The retailer has avoided the lengthy process of gaining a medicinal licence in order to get it onto shelves across the UK.

Government advisors made it legal to buy CBD oil in England and Wales in 2016 and admitted it had a ‘restoring, correcting or modifying’ effect on humans.

Yet, the product’s legal status has confused thousands as the Medicines and Healthcare products Regulatory Agency back-tracked on its position just a few weeks after.

Suppliers therefore have to obtain a licence to sell CBD as a medicine.

An Ocado spokesperson described the product as one of the most interesting its seen

Cannabis oil curbs epilepsy patients’ seizures by more than 50%

Ocado’s news comes after research released yesterday suggested CBD curbs epilepsy patients’ seizures by more than 50 per cent.

Taking the supplement, alongside commonly-prescribed medications, can more than halve the frequency of epilepsy patients’ seizures, a study review by the University of New South Wales found.

The dual treatment also causes nearly one in 10 patients to be seizure-free, while up to half report an improved quality of life after incorporating the supplement into their drug regimen.

Research released last month by Vanderbilt University supported similar outcomes.

Nearly one in three epilepsy patients are resistant to existing treatments and continue to endure seizures.

Read more at DailyMail.co.uk